Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Recent Roche patent reports new therapeutic agents for urological disorders

June 9, 2008

Nabi receives a USD 2.5 million milestone payment from Fresenius for CARE-2 study

June 6, 2008

Altus reports top-line results from ALTU-237 phase I clinical trial

June 4, 2008

Nymox reports significant improvement in BPH symptoms after NX-1207 treatment

May 30, 2008

EMEA notified by sanofi-aventis of its withdrawal of the MAA for Aquilda

May 30, 2008

Rolling NDA commences for Lucassin in hepatorenal syndrome type 1

May 29, 2008

FDA accepts for filing Watson's NDA for oxybutynin chloride topical gel for overactive bladder

May 29, 2008

PNU-165442G improves stress urinary incontinence in women in phase II study

May 27, 2008

Indevus licenses Canadian rights for Sanctura XR to Allergan

May 23, 2008

Omeros initiates patient enrollment in phase I OMS-201 study

May 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...